Study Supports FDA Advisory Committee Conflict-Of-Interest Waivers
This article was originally published in The Gray Sheet
Executive Summary
Constructing FDA advisory committees free from any conflicts of interest would be expensive and time-consuming and would likely exclude many of the most highly qualified candidates, according to an analysis commissioned by the agency